In this Article, unless otherwise specified:
1.
"Accession number" means a unique number, separate
from a medical record number, assigned by a hospital's cancer registry to a
patient for identification purposes.
2.
"Admitted" means the same as in A.A.C.
R9-10-201
.
3.
1. "Analytic patient" means a patient, who
is:
a. Diagnosed at a facility, or
b. Administered any part of a first course of
treatment at the facility.
4.
"Basal cell" means a cell of the inner-most layer of
the skin.
5.
"Behavioral health service agency" means the same as
"agency" in A.A.C.
R9-20-101.
6.
"Business day" means any day of the week other than
a Saturday, a Sunday, a legal holiday, or a day on which the Department is
authorized or obligated by law or executive order to close.
7.
"Calendar day" means any day of the week, including
a Saturday or a Sunday.
8.
2. "Calendar year"
means January 1 through December 31.
9.
3. "Cancer" means a
group of diseases characterized by uncontrolled cell growth and the spread of
abnormal cells.
10.
4. "Cancer registry" means a unit within a hospital or
clinic that collects, stores, summarizes, distributes, and maintains
information specified in
R9-4-403 about
patients who:
a. Are admitted to the
hospital;
b. Receive diagnostic
evaluation at, or cancer-directed treatment from, the hospital or clinic;
or
c. Show evidence of cancer,
carcinoma in situ, or a benign tumor of the central nervous system while
receiving treatment from the hospital or clinic.
11.
5.
"Carcinoma" means a type of cancer that is characterized as a malignant tumor
derived from epithelial tissue.
12.
6. "Carcinoma in situ"
means a cancer that is confined to epithelial tissue within the site of
origin.
13.
7. "Case report" means an electronic or paper document
that includes the information in
R9-4-403 for a
patient.
14.
8. "Chemotherapy" means the treatment of cancer using
specific chemical agents or drugs that are selectively destructive to malignant
cells and tissues.
15.
9. "Clinic" means a facility that is not physically
connected to or affiliated with a hospital, where a physician, doctor of
naturo-pathic medicine, dentist, or registered nurse practitioner provides
cancer diagnosis, cancer treatment, or both, and that is:
a. An outpatient treatment center, as defined
in A.A.C.
R9-10-101;
b. An outpatient surgical center, as defined
in A.A.C.
R9-10-101;
c. An outpatient radiation treatment center;
or
d. A private office of one or
more physicians, doctors of naturopathic medicine, dentists, or registered
nurse practitioners that:
i. Is exempt from
licensing under A.R.S. §
36-402(A)(3),
and
ii. Treats 50 or more cancer
patients per year.
16.
10. "Clinical evaluation" means an examination of the
body of an individual for the presence of disease or injury to the body, and
review of any laboratory test results for the individual by a physician, doctor
of naturopathic medicine, dentist, or registered nurse practitioner.
17.
11.
"Clinical or pathological" means an analysis of evidence either acquired solely
before a first course of treatment was initiated, or acquired both before a
first course of treatment, and supplemented or modified by evidence acquired
during and subsequent to surgery or other treatment.
18. "Code" means a single number
or letter, a set of numbers or letters, or a set of both numbers and letters,
that represents specific information.
19.
12.
"Cytology" means the microscopic examination of cells.
20.
13.
"Date of first contact" means the day, month, and year a reporting facility
first began to provide cancer-related medical services, nursing services, or
health-related services, as defined in A.R.S. §
36-401,
to a patient.
21.
14. "Date of last contact" means the day, month, and
year that a reporting facility last knew a patient to be alive.
22.
15.
"Designee" means a person assigned by the governing authority, as defined in
A.R.S. §
36-401,
of a hospital or clinic or by an individual acting on behalf of the governing
authority to gather information for or report to the Department, as specified
in
R9-4-403 or
R9-4-404.
23.
"Discharge" means the same as in A.A.C.
R9-10-201.
24.
"Discharge date" means the month, day, and year when
a patient is discharged from a hospital.
25.
"Disease progression" means the process of a disease
becoming more severe or spreading from one area of a human body to another area
of the human body.
26.
16. "Distant lymph
node" means a lymph node that is not in the same general area of a human body
as the primary site of a tumor.
27.
17. "Distant site"
means an area of a human body that is not adjacent to or in the same general
area of the human body as the primary site of a tumor.
28.
18.
"Doctor of naturopathic medicine" means an individual licensed under A.R.S.
Title 32, Chapter 14.
29. "Electronic" means the same as
in A.R.S. §
44-7002.
30.
19.
"First course of treatment" means the initial set of cancer- or
non-cancer-directed treatment that is planned and administered to the patient
when a cancer is diagnosed.
31.
20. "Follow-up report"
means an electronic document that includes the information stated in
R9-4-404(A)(2)
for a patient.
32.
"Governing authority" means the same as in A.R.S.
§
36-401.
33.
"Grade" means the degree of resemblance of a tumor
to normal tissue, and gives an indication of the severity of the
cancer.
34.
"Health care institution" means the same as in
A.A.C.
R9-10-101.
35.
"Histology" means the microscopic structure of
cells, tissues, and organs in relation to their function.
36.
21.
"Inpatient beds" means the same as in A.R.S. §
36-401.
37. "Laterality" means the side of
a paired organ or the side of the body in which the primary site of a tumor is
located.
38.
22. "Licensed
capacity" means the same as in A.R.S. §
36-401.
39.
23.
"Lymph" means the clear, watery, sometimes faintly yellowish fluid that
circulates throughout the lymphatic system.
40.
24. "Lymph node" means
any of the small bodies located along lymphatic vessels, particularly at the
neck, armpit, and groin, that filter bacteria and foreign particles from
lymph.
41.
25. "Lymphatic system" means the organ system that
consists of lymph, lymph nodes, and vessels or channels that contain and convey
lymph throughout a human body.
42.
26. "Malignant" means
an inherent tendency of a tumor to sequentially spread to areas of a human body
beyond the site of origin.
43.
27. "Medical record
number" means a unique number assigned by a hospital, clinic, physician, doctor
of naturopathic medicine, dentist, or registered nurse practitioner to an
individual for identification purposes.
44.
28. "Melanocyte" means
a skin cell that makes melanin, which is a dark pigment.
45.
29.
"Melanoma" means a dark-pigmented, malignant tumor arising from a melanocyte
and occurring most commonly in the skin.
46.
30. "Metastasis" means the spread of a cancer from a
primary site into a regional site or a distant site.
47.
31. "Narrative
description" means a written text describing an act, occurrence, or course of
events.
48.
32. "Organ" means a somewhat independent part of a
human body, such as a heart or a kidney, that performs a specific
function.
49.
33. "Organ system" means one or more organs and
associated tissues that perform a specific function, such as the circulatory
system.
50.
34. "Outpatient radiation treatment center" means a
facility regulated under 9 A.A.C.
7 that provides radiation treatment.
51.
"Papillary tumor" means a benign tumor of the skin
producing finger-like projections from the skin surface.
52.
"Pathology laboratory" means a facility in which
human cells or tissues are examined for the purpose of diagnosing cancer and
that is licensed under 9 A.A.C. 10, Article 1.
53.
35.
"Patient" means an individual who has been diagnosed with a cancer, carcinoma
in situ, or benign tumor of the central nervous system:
a. Including melanoma; and
b. Excluding skin cancer that :
a.
i. Is confined to the primary site, or
ii. Was diagnosed after January 1,
2003.
b. Present at regional sites or
distant sites, but was diagnosed on or after January 1, 2003.
54.
36. "Primary site" means a specific organ
or organ system within a human body where the first cancer tumor originated.
55.
37. "Principal diagnosis" means the primary condition
for which an individual is admitted to a hospital or treated by the hospital.
56.
38. "Radiation treatment" means the exposure of a
human body to a stream of particles or electromagnetic waves for the purpose of
selectively destroying certain cells or tissues.
57.
39. "Reconstructive
surgery" means a medical procedure that involves cutting into a body tissue or
organ with instruments to repair damage or restore function to, or improve the
shape and appearance of, a body structure that is missing, defective, damaged,
or misshapen by cancer or cancer-directed therapies.
58. "Recurrence" means the
reappearance of a tumor after previous removal or treatment of the tumor, after
a period in which the patient was believed to be free of
cancer.
59.
40. "Reference date" means the date on
which the hospital's cancer registry began reporting patient information to the
Department.
60.
41. "Regional lymph node" means a lymph node that is
in the same general area of a human body as the primary site of a tumor.
61.
42. "Regional site" means an area of a human body that
is adjacent to or in the same general area of the human body as the primary
site of a tumor.
62.
"Registered nurse practitioner" means an individual
who meets the definition of registered nurse practitioner in A.R.S. §
32-1601,
and is licensed under A.R.S. Title 32, Chapter 15.
63.
"Rehabilitation services" means the same as in
A.A.C.
R9-10-201.
64.
43.
"Release" means to transfer care of a patient from a hospital to a physician, a
doctor of naturopathic medicine, a registered nurse practitioner, an outpatient
treatment center, another hospital, the patient, the patient's parent if the
patient is under 18 years of age and unmarried, or the patient's legal
guardian.
65.
44. "Reporting facility" means a hospital, clinic,
physician, doctor of naturopathic medicine, dentist, or registered nurse
practitioner that submits a case report to the Department.
66.
45.
"Secondary diagnosis" means all other diagnoses of an individual that may be
related to cancer made after the principal diagnosis.
67. "Sequence number" means a
unique number assigned by a cancer registry to a specific cancer within the
body of a patient.
68.
46. "Skin cancer"
means cancer of any of the following types:
a.
Papillary tumor, a tumor of the skin producing finger-like projections from the
skin surface;
b. Squamous cell, a
flat, scale-like skin cell that forms part of the surface of the
skin;
c. Basal cell, a cell of the
inner-most layer of the skin; or
d.
Other carcinoma of the skin, where a specific diagnosis has not been
determined.
69.
"Special hospital" means the same as in A.A.C.
R9-10-201
.
70.
"Squamous cell" means a flat, scale-like skin
cell.
71.
47. "Stage group"
means a scheme for categorizing a patient, based on the staging classification
of the patient's cancer, to enable a physician, doctor of naturopathic
medicine, or registered nurse practitioner to provide better treatment and
outcome information to the patient.
72.
48. "Staging
classification" means the categorizing of a cancer according to the size and
spread of a tumor from its primary site, based on an analysis of three basic
components:
a. The tumor at the primary
site,
b. Regional lymph nodes,
and
c. Metastasis.
73.
"Subsite" means a specific area within a primary
site where a cancer tumor originated.
74.
"Substantiate stage" means a narrative describing
the stage group of a cancer at the time of diagnosis.
75.
"Treatment" means the administration to a patient of
medical services, nursing services, or health-related services, as defined in
A.R.S. §
36-401,
that are intended to relieve illness or injury.
76.
49.
"Tumor" means an abnormal growth of tissue resulting from uncontrolled
multiplication of cells and serving no physiological function.
77.
"Usual industry" means the primary type of activity
carried out by the business where a patient was employed for the most number of
years of the patient's working life before the diagnosis of
cancer.
78.
"Usual occupation" means the kind of work performed
during the most number of years of a patient's working life before the
diagnosis of cancer.
79.
"Working life" means that portion of a patient's
life during which the patient was employed for a salary or
wages.
